Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Feb 27, 2025; 17(2): 102444
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.102444
Unmasking gastric carcinoma: Unveiling diagnostic biomarkers and the role of critical care
Qun-Zhe Ding, Rui-Lan Wang, Yun Xie
Qun-Zhe Ding, School of Information Management, Wuhan University, Wuhan 430072, Hubei Province, China
Rui-Lan Wang, Yun Xie, Intensive Care Unit, Shanghai General Hospital, Shanghai 201600, China
Co-corresponding authors: Rui-Lan Wang and Yun Xie.
Author contributions: Ding QZ contributed to methodology, formal analysis, writing- original draft; Xie Y and Wang RL contributed to conceptualization, methodology, supervision, writing-review and editing.
Conflict-of-interest statement: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yun Xie, MD, Associate Chief Physician, Intensive Care Unit, Shanghai General Hospital, No. 650 New Songjiang Road, Shanghai 201600, China. 772723513@qq.com
Received: October 18, 2024
Revised: November 16, 2024
Accepted: December 4, 2024
Published online: February 27, 2025
Processing time: 96 Days and 21.4 Hours
Core Tip

Core Tip: This commentary highlights the potential of using neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index as cost-effective early diagnostic markers for gastric carcinoma, emphasizing their significance in critical care and the need for further research to incorporate these markers into a multi-modal diagnostic approach for improved patient outcomes.